Jason Barry-Smith

Jason Barry-Smith

Ask VT AI
View News Summary
  • Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
  • Nasdaq proposes stricter listing rules to enhance investor protection and market integrity, including higher minimum public float and capital raise requirements for Chinese firms.
  • Porsche AG, a luxury sports car maker, is being removed from Germany's DAX index due to a significant decline in its share price and profitability amid global trade tensions and sector-specific challenges.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
  • Nasdaq proposes stricter listing rules to enhance investor protection and market integrity, including higher minimum public float and capital raise requirements for Chinese firms.
  • Porsche AG, a luxury sports car maker, is being removed from Germany's DAX index due to a significant decline in its share price and profitability amid global trade tensions and sector-specific challenges.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Jason Barry-Smith